Health · Full coverage
Israeli-led study reports major breakthrough in high-risk bladder cancer treatment
How 2 Israeli newsrooms covered this story — translated into English and compared side by side.
100% right-leaningFirst reported by Arutz Sheva · Jun 14, 2026
Right 2
What happened
A Shaare Zedek-led international study reports major success for a new bladder cancer treatment called NDV-01. Researchers say it produced high complete-response rates, no serious side effects, and could reshape global care if later-stage trials confirm the findings.
- 0195% of patients had complete tumor disappearance within three months.
- 0276% were cancer-free after one year, and 80% of resistant cases responded.
- 03NDV-01 uses a biodegradable gel to deliver chemotherapy inside the bladder for 14 days.
- 04No serious side effects were reported, and all patients finished treatment.
- 05The company now plans large phase 3 trials to seek global adoption.
Summary translated & synthesized from the sources below by baba. Read each original for the full report.
Full coverage · 2 outlets
The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.
Related stories
Cancer Vaccine Shows Promise, Leaving One Patient Disease-Free for More Than Six YearsJun 11, 2026Liquid Biopsy Blood Test Helps Israeli Woman Beat Metastatic Breast CancerMar 8, 2026Health Ministry Finds Serious Illegal Use of Experimental Treatment at Bnei Brak HospitalJun 14, 2026Experimental CAR-T Therapy Puts 19-Year-Old With Rare Vasculitis Into Remission2 days ago22-Year-Old Who Came to the Hospital After an Injury Was Diagnosed With a Rare, Deadly CancerJun 10, 2026Metastatic Breast Cancer Treatment Is Undergoing a Revolution, as Esther Shamir’s Death Highlights the Disease’s TollJun 11, 2026
